Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 119

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9B
Chunk 119
---
 the 5-year U.S. Treasury yield curve in effect at the time of grant.
The Company recognizes forfeitures as they occur.

During
the year ended December 31, 2024, a total of 2,370,170
options to purchase Common Stock, with an aggregate fair market value of approximately $9.1
million with a weighted average fair value per share of $3.83 were granted to the members of the Company’s Board of Directors,
executive officers, employees and consultants of the Company. The options have an exercise price of $5.02,
a term of 10
years from the grant date, and vest over various terms ranging from immediate vesting upon grant to the second anniversary of the
grant date.

The
following is option activity during the year ended December 31, 2024.

 Schedule
of option activity

    Number
                                            of shares  
    Weighted average
                                             exercise
                                            price per
                                            share  
    Aggregate intrinsic
                                            value 
  
    Outstanding as January 1, 2024 
     -  
    $-  
    $            - 
  
    Options granted 
     2,370,170  
     5.02  
     - 
  
    Forfeitures 
     (17,500) 
     5.02  
     - 
  
    Outstanding as December 31, 2024 
     2,352,670  
    $5.02  
    $- 

As
of December 31, 2024, options exercisable totaled 2,352,670. The Company recognized approximately $6.9 million in stock-based compensation
in 2024. There are approximately $2.2 million of unrecognized compensation cost
related to non-vested share-based compensation awards, which will be expensed through 2026.

Schedule of non vested share based compensation

     Exercise Price  
    Number
    Outstanding  
    Weighted
    Average Remaining Contractual Life (Years)  
    Weighted
    Average Exercise Price  
    Number
    Exercisable  
    Aggregate
    Intrinsic Price 
  
    $5.02  
     2,352,670  
     9.6  
    $5.02  
     1,046,335  
    $- 

Key
assumptions used to value stock